GLAXOSMITHKLINE PHARMACEUTICALS
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹169 Cr | ₹169 Cr | ₹169 Cr | ₹169 Cr | ₹169 Cr |
| Equity - Authorised | ₹180 Cr | ₹180 Cr | ₹180 Cr | ₹180 Cr | ₹180 Cr |
| Equity - Issued | ₹169 Cr | ₹169 Cr | ₹169 Cr | ₹169 Cr | ₹169 Cr |
| Equity Paid Up | ₹169 Cr | ₹169 Cr | ₹169 Cr | ₹169 Cr | ₹169 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | ₹-15 Cr | ₹-9.01 Cr | ₹-1.68 Cr | - | - |
| Total Reserves | ₹1,797 Cr | ₹1,617 Cr | ₹1,574 Cr | ₹2,494 Cr | ₹1,309 Cr |
| Securities Premium | - | - | - | - | - |
| Capital Reserves | ₹-19 Cr | ₹-19 Cr | ₹-19 Cr | ₹-19 Cr | ₹-19 Cr |
| Profit & Loss Account Balance | ₹1,059 Cr | ₹876 Cr | ₹829 Cr | ₹1,743 Cr | ₹556 Cr |
| General Reserves | ₹779 Cr | ₹779 Cr | ₹779 Cr | ₹779 Cr | ₹779 Cr |
| Other Reserves | ₹-21 Cr | ₹-19 Cr | ₹-14 Cr | ₹-8.43 Cr | ₹-6.58 Cr |
| Reserve excluding Revaluation Reserve | ₹1,797 Cr | ₹1,617 Cr | ₹1,574 Cr | ₹2,494 Cr | ₹1,309 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹1,951 Cr | ₹1,778 Cr | ₹1,741 Cr | ₹2,663 Cr | ₹1,478 Cr |
| Minority Interest | - | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | - | - | - | - |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | - | - | - | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | - | - | - |
| Unsecured Loans | - | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹-141 Cr | ₹-146 Cr | ₹-134 Cr | ₹-113 Cr | ₹-103 Cr |
| Deferred Tax Assets | ₹168 Cr | ₹163 Cr | ₹152 Cr | ₹132 Cr | ₹119 Cr |
| Deferred Tax Liability | ₹27 Cr | ₹17 Cr | ₹18 Cr | ₹19 Cr | ₹16 Cr |
| Other Long Term Liabilities | ₹2.49 Cr | ₹6.57 Cr | ₹4.14 Cr | ₹9.68 Cr | ₹22 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹249 Cr | ₹247 Cr | ₹255 Cr | ₹262 Cr | ₹259 Cr |
| Total Non-Current Liabilities | ₹111 Cr | ₹108 Cr | ₹125 Cr | ₹159 Cr | ₹179 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹708 Cr | ₹625 Cr | ₹428 Cr | ₹579 Cr | ₹466 Cr |
| Sundry Creditors | ₹708 Cr | ₹625 Cr | ₹428 Cr | ₹579 Cr | ₹466 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹256 Cr | ₹207 Cr | ₹185 Cr | ₹504 Cr | ₹450 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹6.61 Cr | ₹7.55 Cr | ₹7.08 Cr | ₹4.35 Cr | ₹4.91 Cr |
| Interest Accrued But Not Due | - | - | - | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹249 Cr | ₹200 Cr | ₹178 Cr | ₹499 Cr | ₹445 Cr |
| Short Term Borrowings | - | - | - | - | - |
| Secured ST Loans repayable on Demands | - | - | - | - | - |
| Working Capital Loans- Sec | - | - | - | - | - |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | - | - | - | - | - |
| Short Term Provisions | ₹941 Cr | ₹692 Cr | ₹714 Cr | ₹615 Cr | ₹438 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹525 Cr | ₹299 Cr | ₹296 Cr | ₹296 Cr | ₹164 Cr |
| Provision for post retirement benefits | ₹5.01 Cr | ₹4.78 Cr | ₹4.48 Cr | ₹3.42 Cr | ₹3.36 Cr |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹411 Cr | ₹389 Cr | ₹413 Cr | ₹316 Cr | ₹271 Cr |
| Total Current Liabilities | ₹1,905 Cr | ₹1,525 Cr | ₹1,326 Cr | ₹1,698 Cr | ₹1,355 Cr |
| Total Liabilities | ₹3,967 Cr | ₹3,410 Cr | ₹3,193 Cr | ₹4,520 Cr | ₹3,012 Cr |
| ASSETS | |||||
| Gross Block | ₹667 Cr | ₹663 Cr | ₹634 Cr | ₹592 Cr | ₹601 Cr |
| Less: Accumulated Depreciation | ₹384 Cr | ₹343 Cr | ₹305 Cr | ₹262 Cr | ₹215 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹283 Cr | ₹320 Cr | ₹329 Cr | ₹329 Cr | ₹386 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹14 Cr | ₹14 Cr | ₹20 Cr | ₹31 Cr | ₹13 Cr |
| Non Current Investments | - | - | - | - | - |
| Long Term Investment | - | - | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | - |
| Long Term Loans & Advances | ₹259 Cr | ₹275 Cr | ₹347 Cr | ₹445 Cr | ₹402 Cr |
| Other Non Current Assets | ₹0.46 Cr | ₹1.24 Cr | ₹1.10 Cr | ₹5.45 Cr | ₹7.05 Cr |
| Total Non-Current Assets | ₹557 Cr | ₹612 Cr | ₹699 Cr | ₹812 Cr | ₹809 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹1,118 Cr | ₹813 Cr | ₹518 Cr | ₹366 Cr | - |
| Quoted | ₹1,118 Cr | ₹813 Cr | ₹518 Cr | ₹366 Cr | - |
| Unquoted | - | - | - | - | - |
| Inventories | ₹482 Cr | ₹525 Cr | ₹460 Cr | ₹535 Cr | ₹547 Cr |
| Raw Materials | ₹113 Cr | ₹107 Cr | ₹104 Cr | ₹107 Cr | ₹91 Cr |
| Work-in Progress | ₹0.94 Cr | ₹0.81 Cr | ₹0.95 Cr | ₹0.88 Cr | ₹1.30 Cr |
| Finished Goods | ₹113 Cr | ₹99 Cr | ₹101 Cr | ₹151 Cr | ₹128 Cr |
| Packing Materials | - | - | - | - | - |
| Stores  and Spare | ₹0.85 Cr | ₹4.00 Cr | ₹3.85 Cr | ₹3.88 Cr | ₹3.79 Cr |
| Other Inventory | ₹254 Cr | ₹314 Cr | ₹250 Cr | ₹272 Cr | ₹322 Cr |
| Sundry Debtors | ₹293 Cr | ₹222 Cr | ₹192 Cr | ₹205 Cr | ₹216 Cr |
| Debtors more than Six months | ₹18 Cr | ₹16 Cr | ₹17 Cr | ₹26 Cr | ₹25 Cr |
| Debtors Others | ₹291 Cr | ₹220 Cr | ₹188 Cr | ₹200 Cr | ₹211 Cr |
| Cash and Bank | ₹1,404 Cr | ₹1,063 Cr | ₹1,156 Cr | ₹2,485 Cr | ₹1,158 Cr |
| Cash in hand | - | - | - | - | - |
| Balances at Bank | ₹1,404 Cr | ₹1,063 Cr | ₹1,156 Cr | ₹2,485 Cr | ₹1,158 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹87 Cr | ₹150 Cr | ₹155 Cr | ₹89 Cr | ₹46 Cr |
| Interest accrued on Investments | ₹8.95 Cr | ₹9.01 Cr | ₹14 Cr | ₹7.64 Cr | ₹7.51 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹19 Cr | ₹21 Cr | ₹15 Cr | ₹14 Cr | ₹15 Cr |
| Other current_assets | ₹60 Cr | ₹121 Cr | ₹126 Cr | ₹68 Cr | ₹24 Cr |
| Short Term Loans and Advances | ₹26 Cr | ₹25 Cr | ₹12 Cr | ₹28 Cr | ₹56 Cr |
| Advances recoverable in cash or in kind | ₹5.45 Cr | ₹9.18 Cr | ₹7.84 Cr | ₹19 Cr | ₹10 Cr |
| Advance income tax and TDS | - | - | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹21 Cr | ₹16 Cr | ₹4.38 Cr | ₹9.73 Cr | ₹46 Cr |
| Total Current Assets | ₹3,410 Cr | ₹2,798 Cr | ₹2,494 Cr | ₹3,708 Cr | ₹2,023 Cr |
| Net Current Assets (Including Current Investments) | ₹1,505 Cr | ₹1,273 Cr | ₹1,168 Cr | ₹2,009 Cr | ₹668 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹3,967 Cr | ₹3,410 Cr | ₹3,193 Cr | ₹4,520 Cr | ₹3,012 Cr |
| Contingent Liabilities | ₹465 Cr | ₹387 Cr | ₹354 Cr | ₹355 Cr | ₹491 Cr |
| Total Debt | - | - | - | - | ₹0.02 Cr |
| Book Value | - | 105.47 | 102.89 | 157.19 | 87.26 |
| Adjusted Book Value | 116.06 | 105.47 | 102.89 | 157.19 | 87.26 |
Compare Balance Sheet of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹42,628.7 Cr | 1.1% | -4.1% | 3.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,412.0 Cr | -0.4% | 6.4% | 4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,343.0 Cr | -1.5% | -4.9% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,191.0 Cr | -0.7% | 4.8% | 16.6% | Stock Analytics | |
| CIPLA | ₹122,511.0 Cr | -0.5% | 1% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,523.0 Cr | 2.2% | 6.6% | 5.7% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 1.1% |
-4.1% |
3.5% |
| SENSEX | 0.7% |
0.9% |
6.1% |
You may also like the below Video Courses